COGENTIX MEDICAL, INC. (NASDAQ:CGNT) Files An 8-K Results of Operations and Financial Condition

COGENTIX MEDICAL, INC. (NASDAQ:CGNT) Files An 8-K Results of Operations and Financial Condition

Story continues below

Item 2.02.

Results of Operations and Financial Condition
On March 9, 2017, Cogentix Medical, Inc. (the Company) issued a
press release providing information regarding its results of
operations and financial condition for the fiscal quarter and
year ended December 31, 2016.
The Company is furnishing the information contained in this
report, including Exhibit 99.1, to Item 2.02 of Form 8-K
promulgated by the Securities and Exchange Commission (the SEC).
This information shall not be deemed to be filed with the SEC for
the purposes of Section 18 of the Securities Exchange Act of
1934, as amended (the Exchange Act), or otherwise subject to the
liabilities of that section, nor shall it be deemed to be
incorporated by reference in any filing under the Securities Act
of 1933, as amended, or the Exchange Act, except as expressly set
forth by specific reference in such filing.
Item 9.01
Financial Statements and Exhibits.
(d)
Exhibits.
Exhibit No.
Description
99.1
Press Release of Cogentix Medical, Inc. dated March 9, 2017
(furnished herewith)


About COGENTIX MEDICAL, INC. (NASDAQ:CGNT)

Cogentix Medical, Inc. is a global medical device company. The Company designs, develops, manufactures and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand that are used across various surgical specialties in diagnostic and treatment procedures. The Company also offers the Urgent PC Neuromodulation System (Urgent PC Systems), a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB). The Company also offers Macroplastique Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence that is primarily due to intrinsic sphincter deficiency. The PrimeSight flexible endoscopes are used in conjunction with the sterile, single-use microbial barrier known as the EndoSheath Protective Barrier. The PrimeSight endoscopy line also includes rigid endoscopes and portable peripherals, such as the video system and stroboscopy unit.

COGENTIX MEDICAL, INC. (NASDAQ:CGNT) Recent Trading Information

COGENTIX MEDICAL, INC. (NASDAQ:CGNT) closed its last trading session 00.00 at 2.21 with 90,864 shares trading hands.

An ad to help with our costs